-+ 0.00%
-+ 0.00%
-+ 0.00%

Traws Pharma Announces Approval for Phase 2 Trials of Ratutrelvir, Anticipates Results by Year-End 2025

Reuters·08/18/2025 11:02:20

Please log in to view news